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Neoplastic cell transfonnation induced by estrogens and some other carcinogen& such as benzene appears 
to involve the induction of mitotic aneuploidy rather than DNA damage and point mutations. As metabolic 
activation may also play an important roJe in the mechanism of carcinogenesis of these nongenotoxic 
compounds, we have studied the Interaction of reactive quinone metabolites of various estrogens and of 
benzene with the major microtubular protein, tubulin, in a cell-free system. Covalent binding of the 
radioactively labeled metabolites to the a- and 13-subunit of tubulin was found to depend on the structure 
of the metabolite. When the adducted tubulins were tested in vitro for their ability to polymerize to 
microtubules, Inhibition of microtubule assembly was obsened in every case, although to varying extents. 
It is proposed that the fonnation of covalent tubulin adducts may impair the formation of mitotic spindies 
and thus contribute to chromosomal nondisjunction and aneuploidy induction. 
lntroduction 
I t is weil established that certain estrogens can induce 
cancer in experimental animals and are associated with 
tumor formation in man (1). However, the mechanisms 
underlying estrogen-mediated tumorigenesis are far 
from clear. There is a general consensus that hormonally 
active compounds may act as promoters of cancer, in 
particular in cells responding to the hormones by 
growth. It is, however, still a matter of debate whether 
estrogens have the ability to induce cancer independent 
of their hormonal activity. 
A suitable experimental system for studying the non-
hormonal mechanism of estrogen carcinogenesis makes 
use of Syrian hamster embryo (SHE) fibroblasts. These 
cells are devoid of detectable Ievels of estrogen recep-
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tors, and their growth is not influenced by estrogens 
(2); nevertheless, they are neoplastically transformed 
by a variety of natural and synthetic estrogens (2,3). 
Most interestingly, transformation has been shown to 
occur in the absence of detectable point mutations (3-
5). Instead, the induction of near-diploid aneuploidy 
(3,5) and of micronuclei (6) was observed in these cells, 
and a chromosomal mechanism has been proposed for 
cell transformation by estrogens (5). The transforming 
capability of a number of estrogens did not correlate 
with their hormonal potency but rather with structural 
features, suggesting that metabolic pathways may be 
of importance for cell transformation. In particular, per-
oxidase-mediated oxidation appears to be crucial in the 
metabolic activation of estrogens (2). 
In order to elucidate the role of peroxidative es trogen 
metabolites in the biochemical mechanism of aneuploidy 
induction, we have studied the covalent binding of these 
metabolites to microtubular proteins in vitro, as weil 
as the functional consequences of such adduct formation 
for microtubule assembly. Hydroquinone, a major me-
tabolite of the human carcinogen benzene, was included 
in these sturlies because it also has the ability to undergo 
peroxidative metabolism. 
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Methods 
Covalent Tubulin Binding 
14C-Diethylstilbestrol e4C-DES) or 14C-hydroqui-
none (33 ...,M in 1 mM phosphate buffer, pH 7.5) was 
incubated with horseradish peroxidase (HRP; 1. 9 U I 
mL) and H202 (825 J.LM) for 10 min at 25°C. The oxi-
dation was stopped by addition of catalase (final con-
centration, 315 U/mL). 
Aliquots of the incubation mixture containing ~uinoid 
metabolites thus generated or of a solution of 4C-N-
ethylmaleimide (NEM) in phosphate buffer were added 
to twice-cycled bovine microtubule protein (3 J.LM) (7) 
in reassembly buffer [100 mM 2-(N-morpholino)-ethane-
sulfonic acid, 1 mM ethyleneglycol-bis-(ß-aminoethyl-
ether)-N,N,N',N'-tetraacetic acid, 0.5 mM MgC12 , pH 
6.4] and incubated for 30 min at 37°C. Microtubule as-
sembly was initiated by addition of guanosine triphos-
phate (GTP; final concentration 0.5 mM) and allowed to 
proceed for another 30 min. Protein was precipitated 
by addition of trichloroacetic acid and applied to sodium 
dodecyl sulfate (SDS, 7.5%, polyacrylamide gels for 
electrophoresis. After Coomassie blue staining, the 
dried gels were analyzed by autoradiography and by 
combustion of excised gel slices in a Packard 306 sample 
oxidizer, followed by liquid scintillation counting. 
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Microtubule Assembly 
Tubulin was incubated with quinoid metabolites or 
unmetabolized compounds as described above. GTP was 
added, and the increase in turbidity at 350 nm was de-
termined after 30 min. Values obtained from incubations 
in which the test compounds were omitted served as 
reference (100% assembly). Aggregation oftubulin was 
assumed if the increase in turbidity was not at least 80% 
reversible on incubation for 30 min at 4°C or if electron 
microscopy revealed precipitated material other than 
microtubules. 
Results 
Covalent Tubulin Binding 
The peroxidative metabolism of stilbene-type estro-
gens, e.g., diethylstilbestrol and indenestrol A, pro-
ceeds via semiquinoid and quinoid intermediates (Fig. 
1). Similarly, catechol metabolites of steroidal estro-
gens, e.g., 2-hydroxy-estradiol, and the benzene me-
tabolite hydroquinone yield semiquinones and quinones 
upon oxidation (Fig. 1). Although the reactivity ofthese 
products with DNA in vitro is rather low, they can very 
efficiently bind toproteins in a covalent manner (8,9). 
In the absence of semiquinone (phenoxy)·radicals (i.e., 
if the oxidation of the estrogens is stopped prior to the 
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FIGURE 1. Peroxidative metabolism of DES, indenestrol A, 2-hydroxyestradiol, and hydroquinone. 
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FIGURE 2. Covalent binding of quinoid metabolites and NEM to the a-subunit (0) and ß-subunit <•> of tubulin. Tubulin (1.5 nmole) was 
incubated in 500 ~L reassembly buffer with 14C-NEM or quinoid metabolites of 14C-DES or 14C-hydroquinone under the same conditions 
as used in the tests for microtubule assembly (Fig. 3). Radioactivity bound to the two subunits of the protein was determined after 
polyacrylamide gel electrophoresis by combustion of excised gel slices. 
addition of the protein) the binding species are most 
probably quinones. For the quinone metabolites of both 
stilbene-type and steroidal estrogens, a rather selective 
binding reaction to the major microtubular protein, 
tubulin, has been observed, which most likely involves 
the C-terminal domain (1 0). 
In Figure 2, the extent of covalent tubulin binding of 
peroxidative metabolites of 14C-DES, generated in vitro 
by reaction with HRP/H202 , is compared with that of 
the corresponding oxidation products of 14C-hydroqui-
none, p-benzoquinone. The binding of NEM, a nonspe-
cific sulfbydryl-reactive compound, was studied in par-
allel. 
The data indicate that both NEM and oxidized hy-
droquinone bind to tubulin to a much higher extent than 
do the metabolites ofDES. This difference is most prob-
ably due to the rapid rearrangement of DES to Z,Z-
dienestrol (Fig. 1) and does not reflect a lower reactivity 
of DES-quinone compared to the other quinones. The 
ratio of labeling of the two subunits of tubulin differs 
for the different compounds tested. While metabolites 
of DES and also of other estrogens such as 2-hydroxy-
estradiol (10) bind preferentially to ß-tubulin, p-ben-
zoquinone causes a higher labeling of the a-subunit. 
NEM binds to both subunits to about the same extent. 
Microtubule Assembly 
The relevance of the covalent binding to tubulin for 
its functional activity was studied by analyzing the GTP-
dependent microtubule assembly in vitro. In addition 
to the compounds tested for covalent binding, indenes-
trol A was included in the assay as another stilbene-
type estrogen capable of forming quinoid metabolites 
(Fig. 1). The inhibition of microtubule assembly by col-
chieine served as a reference. Foreach ofthe estrogens 
and hydroquinone, the effects ofthe quinoid metabolites 
(allowed to bind covalently under the conditions de-
scribed) were compared with those ofthe unmetabolized 
parent compounds. 
The results shown in Figure 3 indicate that the me-
tabolites of DES, hydroquinone, and indenestrol A give 
rise to a dose-dependent inhibition of microtubule as-
sembly. The effect is most probably a consequence of 
the covalent binding, as it is not observed when the 
reactive quinones are scavenged from the incubation 
mixture with glutathione prior to the addition of tubulin 
(data not shown). High concentrations of metabolites 
give rise to an irreversible aggregation of tubulin as 
indicated by its failure to depolymerize at 4°C and by 
electron microscopy. A similar effect is observed with 
NEM (Fig. 3). Unmetabolized hydroquinone and in-
denestrol A do not affect microtubule assembly in the 
concentration range tested, while DES inhibits signif-
icantly (Fig. 3). As DES undergoes considerable autox-
idation und er the incubation conditions used ( data not 
shown), it cannot be excluded that the inhibition by DES 
is, at least in part, due to the autoxidation products 
rather than to the parent compound. 
In Table 1, the degree of covalent binding observed 
at 30% inhibition of microtubule assembly is compared 
for NEM and the metabolites ofDES and hydroquinone. 
Assuming that the covalent binding is directly respon-
sible for the inhibition, we conclude from the data that 
the tubulin binding of NEM is much less effective than 
that ofthe quinoid metabolites, especially those ofDES. 
Dlscusslon 
The results presented here demonstrate that quinoid 
metabolites of estrogens can react with tubulin and dis-
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FIGURE 3. Inhibition of microtubule assembly. Tubulin, 1.5 nmole in 500 ~L reassembly buffer, was incubated with either unmetabolized 
compounds (0, 0, 11) or products of peroxidative metabolism <•> for 30 min at 3'rC. Microtubule assembly was started by adding GTP, 
and the increase in turbidity was determined after 30 min. Control incubations containing all components except the test compounds were 
used as reference (100% assembly). Electron microscopy and depolymerization at 4°C were used to confirm microtubule formation and 
detect aggregation. Data are means of three independent experiments ± SD. 
turb its GTP-dependent assembly into microtubules. 
The extent of covalent binding associated with a sig-
nificant inhibition of microtubule assembly is much 
lower than that observed after a nonspecific modification 
of sulfbydryl groups by NEM. 
These findings and the observation reported here and 
earlier that DES has an inhibitory effect on tubulin 
assembly even without covalent binding (11,12), might 
best be explained by postulating a binding site in a 
functionally important domain of tubulin that has affin-
ity for estrogens and can be irreversibly blocked by the 
structurally related quinoid metabolites. If a significant 
covalent modification oftubulin by estrogen metabolites 
takes place in vivo, it may represent the primary lesion 
for the induction of neoplastic cell transformation by 
these compounds, giving rise to chromosomal nondis-
junction and aneuploidy (Fig. 4). 
The similar although apparently less specific inhibi-
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Table 1. Covalent binding to tubulin observed at 30% inhibition 
of microtubule assembly. • 
Compound 
Quinoid metabolites of 
DES 
Hydroquinone 
NEM 
pmole covalent bindingt 
1.5 nmole of 
a-Tubulin ~ Tubulin 
42 ± 5 
185 ± 55 
490 ± 50 
63 ± 6 
135 ± 35 
400 ± 50 
• V alues are calculated from the data shown in Figures 2 and 3. 
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I CELL TRANSFORMATION I 
FIGURE 4. Possible mechanism of cell-transfonnation initiated by 
an interaction with the cytoskeletal protein tubulin that gives rise 
to mutations on the chromosomal Ievel. 
tion of microtubule assembly by peroxidative metab-
olites of hydroquinone and, thereby, secondary me-
tabolites of benzene, suggests that the proposed 
mechanism may be of more general importance for the 
initiation of carcinogenesis. The carcinogenicity of ben-
zene, like that of DES, is also apparently not induced 
by point mutations (13). 
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